Read our latest updates from research breakthroughs to government actions to fundraising heroes.
Caroline had been retired for a couple of years when she was diagnosed with ovarian cancer age of 64 in February 2016. Sadly, she passed away in March 2018. Caroline and her husband Ralph had three children. Zoe set up a tribute page in memory of her mum
Delia Hunt passed away in July 2014 aged 69, just five weeks after being diagnosed with ovarian cancer and primary peritoneal cancer. Her husband Ron set up a MuchLoved tribute page to celebrate her life and legacy and donates in her memory each month.
We’ve put together five tips from our previous wellbeing events, shared by trusted experts and specialists, to help you explore a range of practical advice, sessions and support.
Celebrate how the achievements of our research programme last year (July 2022 – June 2023) are taking us one step closer to improving access to treatments for all.
Dr Sharon Tate, Head of Primary Care at Target Ovarian Cancer, talks to Overlooked podcast host Golda Arther about the importance of GP engagement and how that, along with symptoms awareness, is a needle mover when it comes to progress in ovarian cancer.
The European Society of Medical Oncology congress (ESMO) is held annually to present new clinical data and research findings alongside educational updates and programmes aimed to improve cancer care.
Driving awareness and improvements in ovarian cancer is happening, but your help is vital
After first being diagnosed with stage 4b ovarian cancer in January 2021, Sue took part in the Ovarian Cancer Walk|Run in 2022. This year, she's joining us again!
The support and expertise of Clinical Nurse Specialists (CNSs) is at the heart of ovarian cancer care. Celebrate them with us through our new award.
Hear first-hand from husband and wife, Declan and Pauline, about how our supportive services helped them individually and together.
Learn about our newly launched tools and resources that put support and trusted information in the spotlight. Introducing our new stages tool, PARP inhibitor eligibility tool and Your Wellbeing hub.
From diagnosis and wait times, to accessing the best treatments available, we recognise that there is still a significant variation in experience across the UK. We want to change this.
Sign up to receive emails and keep up to date on all things Target Ovarian Cancer
Sign up
